Cardiac Biomarkers Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global cardiac biomarkers market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global cardiac biomarkers market to grow with a CAGR of 10.2% over the forecast period from 2019-2025. The study on cardiac biomarkers market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on cardiac biomarkers market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cardiac biomarkers market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cardiac biomarkers market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• The rise in the number of patients suffering from acute coronary syndrome (ACS) across the globe
• Rapidly increasing geriatric population
• Development and advancement in cardiac biomarkers

2) Restraints

• Technical problems related to sample collection and storage

3) Opportunities

• Rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global cardiac biomarkers market is segmented on the basis of type, location of testing, and applications.

The Global Cardiac Biomarkers Market by Type

• Myocardial Muscle Creatine Kinase (CK-MB)
• Troponins (T and I)
• Myoglobin
• Brain Natriuretic Peptide (BNPs) Or NT-proBNP
• Ischemia Modified Albumin (IMA)
• Other Types

The Global Cardiac Biomarkers Market by Location of Testing

• Point of Care Testing
• Laboratory Testing

The Global Cardiac Biomarkers Market by Applications

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Other Applications

Company Profiles

The companies covered in the report include

• Beckman Coulter, Inc.
• Roche Diagnostics Limited
• Abbott Laboratories
• bioMérieux SA
• Johnson and Johnson
• Olympus Corporation
• Siemens Healthcare GmbH
• Tosoh Corporation
• F. Hoffmann-La Roche Ltd.
• PerkinElmer Inc.
• Other companies

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the cardiac biomarkers market.
2. Complete coverage of all the segments in the cardiac biomarkers market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global cardiac biomarkers market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.